Atossa Therapeutics ATOS
NASDAQ ATOS
$1.92 -0.11 (-5.17%)
As of: Nov 12, 2026 · 1:13 PM EST

Atossa Therapeutics (ATOS) Cost of Revenue (2011 - 2015)

Updated

Atossa Therapeutics' Cost of Revenue came in at -$3.24 million for Q4 2015.

Analysis

Atossa Therapeutics (ATOS) Cost of Revenue (2011 - 2015) Analysis & Trends

For FY2015, Atossa Therapeutics' Cost of Revenue was $132,411.

  • Cost of Revenue carries a four-year compound annual growth rate of 125.0% (FY2011 to FY2015).
  • Going back by year, Cost of Revenue was $345,519 in FY2013 (+866.6%), $35,745 in FY2012 (+592.2%) and $5,164 in FY2011.
  • The Q4 2015 figure represents the lowest quarterly Cost of Revenue in data going back to Q4 2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 3.93 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.10 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 4.29 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.89 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 2.95 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 2.79 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.57 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.03 Bn
10 Atossa Therapeutics 21.38 Mn -98.31 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 -3.24 Mn
Sep 30, 2015 313,406.00
Sep 30, 2013 25,938.00
Jun 30, 2013 222,160.00
Mar 31, 2013 66,464.00
Dec 31, 2012 5,760.00
Sep 30, 2012 9,000.00
Jun 30, 2012 17,788.00
Mar 31, 2012 3,197.00
Dec 31, 2011 5,164.00
API Access

Atossa Therapeutics Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=ATOS&period=max&api_key=YOUR_API_KEY